U.S., March 18 -- ClinicalTrials.gov registry received information related to the study (NCT07477015) titled 'Study of Pathogenic Mechanisms and Identification of Novel Autoantibodies in Autoimmune Encephalitis' on April 14, 2025.
Brief Summary: Autoimmune encephalitis is a debilitating neurological disorder that usually appears as a rapidly progressive form of brain dysfunction, typically developing in less than six weeks, caused by inflammation in the brain. These conditions show a wide range of clinical and immunological presentations and are generally divided into two main types.
The first type includes what are called paraneoplastic syndromes. In these cases, the immune system produces antibodies in response to a tumor that mistakenl...